A new study found GLP-1 medications may help lower mortality risk for people who have colon cancer, a type of colorectal cancer
The SURMOUNT clinical trial program, which tested tirzepatide for weight loss in over 4,000 people, used once-weekly dosing as the foundation of the treatment protocol
Schedule a consultation today to learn whether GLP-1 treatment fits your goals and discover a supportive, personalized path forward
In 2025, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon
The daily pill, called Foundayo, is the second oral GLP-1 to reach the market in recent months, following the approval of Novo Nordisks Wegovy pill in December